Exchange: NASDAQ·Updated 07:30 PM EST

About KNSA

About

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
366

Frequently Asked Questions

Advertisement|Remove ads.